Weiwei Peng
12 papers in the catalog · Netherlands
Weiwei Peng: 12 papers in the catalog · Netherlands · Netherlands Proteomics Centre, Utrecht University · Works on Anti-MUC1 139H2 reverse engineering, COVID-19 IgG1/IgA1 repertoire profiling, Human plasma IgG1 repertoire profiling
Affiliations
- Netherlands Proteomics Centre
- Utrecht University · Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research
- Utrecht University · Department of Pharmaceutical Sciences
Elsewhere
Papers
- Structural Basis for Postfusion-Specific Binding to the Respiratory Syncytial Virus F Protein by the Canonical Antigenic Site I Antibody 131–2a (2025, ACS Infectious Diseases)
- Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing (2024, Life Science Alliance)
- De novo antibody sequencing based on mass spectrometry (2024)
- Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients (2024, Molecular & Cellular Proteomics)
- Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study (2023, Journal of Proteome Research)
- Reverse engineering the anti-MUC1 hybridoma antibody 139H2 by mass spectrometry-based de novo sequencing (2023, bioRxiv)
- No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients (2022, medRxiv)
- Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire Profiling (2022, Analytical Chemistry)
- Template-based assembly of proteomic short reads for de novo antibody sequencing and repertoire profiling (2022, bioRxiv)
- Human plasma IgG1 repertoires are simple, unique, and dynamic (2021, Cell Systems)
- Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme (2021, Journal of Proteome Research)
- Mass spectrometry-based de novo sequencing of the anti-FLAG-M2 antibody using multiple proteases and a dual fragmentation scheme (2021, bioRxiv)
Methods and tools
Anti-MUC1 139H2 reverse engineering, COVID-19 IgG1/IgA1 repertoire profiling, Human plasma IgG1 repertoire profiling, MGUS M-protein sequencing from serum, Multi-protease dual-fragmentation antibody sequencing, RSV postfusion F antibody 131-2a sequencing, Stitch